For over 60 years, Jane Goodall was a force for research about our precious planet—and climate change action to protect it—while breaking glass ceilings along the way.

I'll so miss her courage and commitment to help expand what we know about our world and preserve it for the generations to come.

Taxpayers and charities helped develop the gene therapy Zolgensma.

Then it debuted at a record price of $2M+ per dose, ushering in a new class of wildly expensive drugs. Its story upends the widely held conception that high prices reflect huge industry investments in innovation.

(Published Feb.)